92 related articles for article (PubMed ID: 38750019)
21. OI inhibits development of ovarian cancer by blocking crosstalk between cancer cells and macrophages via HIF-1α pathway.
Zhan Z; Wang Z; Bao Y; Liu W; Hong L
Biochem Biophys Res Commun; 2022 May; 606():142-148. PubMed ID: 35358838
[TBL] [Abstract][Full Text] [Related]
22. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses.
Chen LL; Morcelle C; Cheng ZL; Chen X; Xu Y; Gao Y; Song J; Li Z; Smith MD; Shi M; Zhu Y; Zhou N; Cheng M; He C; Liu KY; Lu G; Zhang L; Zhang C; Zhang J; Sun Y; Qi T; Lyu Y; Ren ZZ; Tan XM; Yin J; Lan F; Liu Y; Yang H; Qian M; Duan C; Chang X; Zhou Y; Shen L; Baldwin AS; Guan KL; Xiong Y; Ye D
Nat Cell Biol; 2022 Mar; 24(3):353-363. PubMed ID: 35256775
[TBL] [Abstract][Full Text] [Related]
23. Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages.
Runtsch MC; Angiari S; Hooftman A; Wadhwa R; Zhang Y; Zheng Y; Spina JS; Ruzek MC; Argiriadi MA; McGettrick AF; Mendez RS; Zotta A; Peace CG; Walsh A; Chirillo R; Hams E; Fallon PG; Jayamaran R; Dua K; Brown AC; Kim RY; Horvat JC; Hansbro PM; Wang C; O'Neill LAJ
Cell Metab; 2022 Mar; 34(3):487-501.e8. PubMed ID: 35235776
[TBL] [Abstract][Full Text] [Related]
24. A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy.
Carter ME; Hartkopf AD; Wagner A; Volmer LL; Brucker SY; Berchtold S; Lauer UM; Koch A
Front Mol Biosci; 2022; 9():826302. PubMed ID: 35223990
[No Abstract] [Full Text] [Related]
25. Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection.
Sohail A; Iqbal AA; Sahini N; Chen F; Tantawy M; Waqas SFH; Winterhoff M; Ebensen T; Schultz K; Geffers R; Schughart K; Preusse M; Shehata M; Bähre H; Pils MC; Guzman CA; Mostafa A; Pleschka S; Falk C; Michelucci A; Pessler F
PLoS Pathog; 2022 Jan; 18(1):e1010219. PubMed ID: 35025971
[TBL] [Abstract][Full Text] [Related]
26. Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response.
Sato Y; Fu Y; Liu H; Lee MY; Shaw MH
BMC Cancer; 2021 Nov; 21(1):1222. PubMed ID: 34774008
[TBL] [Abstract][Full Text] [Related]
27. Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis.
Bhatt DK; Chammas R; Daemen T
Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696274
[TBL] [Abstract][Full Text] [Related]
28. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Wesseling P; Brat DJ; Cree IA; Figarella-Branger D; Hawkins C; Ng HK; Pfister SM; Reifenberger G; Soffietti R; von Deimling A; Ellison DW
Neuro Oncol; 2021 Aug; 23(8):1231-1251. PubMed ID: 34185076
[TBL] [Abstract][Full Text] [Related]
29. Dopaminergic Neuromodulation of Spike Timing Dependent Plasticity in Mature Adult Rodent and Human Cortical Neurons.
Louth EL; Jørgensen RL; Korshoej AR; Sørensen JCH; Capogna M
Front Cell Neurosci; 2021; 15():668980. PubMed ID: 33967700
[TBL] [Abstract][Full Text] [Related]
30. Itaconate confers tolerance to late NLRP3 inflammasome activation.
Bambouskova M; Potuckova L; Paulenda T; Kerndl M; Mogilenko DA; Lizotte K; Swain A; Hayes S; Sheldon RD; Kim H; Kapadnis U; Ellis AE; Isaguirre C; Burdess S; Laha A; Amarasinghe GK; Chubukov V; Roddy TP; Diamond MS; Jones RG; Simons DM; Artyomov MN
Cell Rep; 2021 Mar; 34(10):108756. PubMed ID: 33691097
[TBL] [Abstract][Full Text] [Related]
31. The KEAP1-NRF2 System as a Molecular Target of Cancer Treatment.
Taguchi K; Yamamoto M
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33375248
[TBL] [Abstract][Full Text] [Related]
32. Cytokines in oncolytic virotherapy.
Pol JG; Workenhe ST; Konda P; Gujar S; Kroemer G
Cytokine Growth Factor Rev; 2020 Dec; 56():4-27. PubMed ID: 33183957
[TBL] [Abstract][Full Text] [Related]
33. Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy.
Groeneveldt C; Kinderman P; van den Wollenberg DJM; van den Oever RL; Middelburg J; Mustafa DAM; Hoeben RC; van der Burg SH; van Hall T; van Montfoort N
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33082167
[TBL] [Abstract][Full Text] [Related]
34. Clinical Application of Oncolytic Viruses: A Systematic Review.
Cook M; Chauhan A
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053757
[TBL] [Abstract][Full Text] [Related]
35. Clinical landscape of oncolytic virus research in 2020.
Macedo N; Miller DM; Haq R; Kaufman HL
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33046622
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
Olagnier D; Farahani E; Thyrsted J; Blay-Cadanet J; Herengt A; Idorn M; Hait A; Hernaez B; Knudsen A; Iversen MB; Schilling M; Jørgensen SE; Thomsen M; Reinert LS; Lappe M; Hoang HD; Gilchrist VH; Hansen AL; Ottosen R; Nielsen CG; Møller C; van der Horst D; Peri S; Balachandran S; Huang J; Jakobsen M; Svenningsen EB; Poulsen TB; Bartsch L; Thielke AL; Luo Y; Alain T; Rehwinkel J; Alcamí A; Hiscott J; Mogensen TH; Paludan SR; Holm CK
Nat Commun; 2020 Oct; 11(1):4938. PubMed ID: 33009401
[TBL] [Abstract][Full Text] [Related]
37. Array programming with NumPy.
Harris CR; Millman KJ; van der Walt SJ; Gommers R; Virtanen P; Cournapeau D; Wieser E; Taylor J; Berg S; Smith NJ; Kern R; Picus M; Hoyer S; van Kerkwijk MH; Brett M; Haldane A; Del Río JF; Wiebe M; Peterson P; Gérard-Marchant P; Sheppard K; Reddy T; Weckesser W; Abbasi H; Gohlke C; Oliphant TE
Nature; 2020 Sep; 585(7825):357-362. PubMed ID: 32939066
[TBL] [Abstract][Full Text] [Related]
38. The anti-inflammatory drug dimethyl itaconate protects against colitis-associated colorectal cancer.
Wang Q; Li XL; Mei Y; Ye JC; Fan W; Cheng GH; Zeng MS; Feng GK
J Mol Med (Berl); 2020 Oct; 98(10):1457-1466. PubMed ID: 32840638
[TBL] [Abstract][Full Text] [Related]
39. The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation.
Hooftman A; Angiari S; Hester S; Corcoran SE; Runtsch MC; Ling C; Ruzek MC; Slivka PF; McGettrick AF; Banahan K; Hughes MM; Irvine AD; Fischer R; O'Neill LAJ
Cell Metab; 2020 Sep; 32(3):468-478.e7. PubMed ID: 32791101
[TBL] [Abstract][Full Text] [Related]
40. Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages.
Swain A; Bambouskova M; Kim H; Andhey PS; Duncan D; Auclair K; Chubukov V; Simons DM; Roddy TP; Stewart KM; Artyomov MN
Nat Metab; 2020 Jul; 2(7):594-602. PubMed ID: 32694786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
